Table 2.
Variable | Univariable Models |
Multivariable Model 1* |
Multivariable Model 2* |
||||||
---|---|---|---|---|---|---|---|---|---|
%Δ† | (95% CI) | p-value | %Δ† | (95% CI) | p-value | %Δ† | (95% CI) | p-value | |
Male sex | 20.8 | (0.8, 44.7) | .041 | 3.4 | (-13.2, 23.2) | .71 | 3.5 | (-13.2, 23.4) | .70 |
Age, per 10-year increase | -4.8 | (-10.1, 0.8) | .093 | 0.5 | (-6.0, 7.4) | .89 | -0.1 | (-6.7, 7.0) | .98 |
White race | -22.2 | (-39.0, -0.9) | .042 | -15.7 | (-32.9, 5.9) | .14 | -14.2 | (-31.8, 7.9) | .19 |
Insurance | .006 | ||||||||
Commercial | (ref) | ||||||||
Medicaid | 47.8 | (12.4, 94.4) | 12.1 | (-14.9, 47.7) | .42 | 26.0 | (-6.4, 69.6) | .13 | |
Medicare | 8.3 | (-17.6, 42.2) | -7.7 | (-30.1, 21.8) | .57 | -1.1 | (-25.2, 30.7) | .94 | |
Other | 13.4 | (-24.7, 70.9) | 1.8 | (-31.4, 51.0) | .93 | 6.6 | (-28.3, 58.3) | .75 | |
SSI | -43.5 | (-53.4, -31.5) | <.001 | -25.4 | (-39.5, -7.9) | .007 | -26.6 | (-41.0, -8.7) | .006 |
Medical comorbidities | |||||||||
Cirrhosis | 42.2 | (-4.1, 111.0) | .080 | 1.1 | (-30.8, 47.5) | .96 | |||
CKD | 56.8 | (23.1, 99.7) | <.001 | 27.7 | (-0.9, 64.4) | .058 | |||
DM | 16.4 | (-5.1, 42.8) | .14 | 7.8 | (-12.4, 32.6) | .48 | |||
Endocarditis | 52.8 | (15.5, 102.1) | .003 | 15.4 | (-13.0, 53.1) | .32 | |||
Chronic SCI/decubitus ulcer | 49.8 | (11.2, 101.9) | .008 | 41.8 | (4.8, 91.7) | .024 | |||
HIV | 66.5 | (-20.6, 249.4) | .18 | 23.3 | (-38.6, 147.6) | .55 | |||
Malnutrition | 101.3 | (62.7, 148.9) | <.001 | 64.8 | (31.8, 106.1) | <.001 | |||
Non-IV drug use | 27.2 | (-16.8, 94.2) | .27 | 18.8 | (-21.0, 78.5) | .41 | |||
IVDU | 35.1 | (10.2, 65.7) | .004 | 6.8 | (-19.0, 40.8) | .64 | |||
Number of comorbidities | <.001 | <.001 | |||||||
0 | (ref) | ||||||||
1 | 49.9 | (21.5, 84.9) | 29.9 | (3.0, 63.7) | |||||
2 | 82.8 | (43.2, 133.5) | 54.6 | (18.2, 102.1) | |||||
3+ | 194.0 | (122.1, 289.0) | 141.5 | (76.7, 229.9) |
LOS, length of stay; PSL, primary spoken language; SSI, surgical site infection; CKD, chronic kidney disease; DM, diabetes mellitus; SCI, spinal cord injury; HIV, human immunodeficiency virus; IV, intravenous; IVDU, intravenous drug user.
396 patients without any missing characteristics were included in the multivariable models;
Percent difference in geometric mean of LOS or charges per change in variable.